Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
暂无分享,去创建一个
Vilmundur Gudnason | Hiroto Hatabu | Andrew P Morris | Michael Ng | Michael H Cho | Carlos Flores | Ke Hao | David C Nickle | Louise V Wain | Martin D Tobin | Brian D Hobbs | John D Newell | Imre Noth | Nik Hirani | Moira K B Whyte | Tasha E Fingerlin | Richard J Allen | Wim Timens | Helen Parfrey | Maria Molina-Molina | Philippe Joubert | Ian Sayers | Ani Manichaikul | Dominic Furniss | L. Wain | R. Allen | M. Obeidat | Y. Bossé | K. Hao | I. Sayers | R. Hubbard | A. Morris | M. Tobin | I. Hall | B. Yaspan | I. Noth | V. Gudnason | D. Nickle | M. Strek | G. O'Connor | D. Schwartz | D. Sin | M. Cho | N. Kaminski | G. Gudmundsson | H. Hatabu | K. Zondervan | Shwu-Fan Ma | J. Newell | T. Fingerlin | P. Sakornsakolpat | A. Manichaikul | B. Hobbs | W. Fahy | W. Timens | Yingze Zhang | T. Maher | P. Molyneaux | B. Guillen-Guio | C. Flores | R. Jenkins | A. Millar | R. McAnulty | V. Ortega | M. Molina-Molina | S. Hart | M. Ng | D. Furniss | D. Lederer | Robin J McAnulty | Brian L Yaspan | David A Schwartz | Don D Sin | G. Hunninghake | Toby M Maher | Yohan Bossé | Ian P Hall | Hanfei Xu | Richard B Hubbard | David J Lederer | M. Whyte | P. Joubert | N. Hirani | J. Oldham | R Gisli Jenkins | Gary M Hunninghake | Gunnar Gudmundsson | A. Adegunsoye | H. Parfrey | H. Booth | M. Hill | Ann B Millar | Xuan Li | M. Paynton | Hanfei Xu | Krina Zondervan | George T O’Connor | Ma’en Obeidat | Amy Dressen | Shwu-Fan Ma | Beatriz Guillen-Guio | Justin M Oldham | Megan L Paynton | Luke M Kraven | Xuan Li | Rebecca Braybrooke | Rachel K Putman | Phuwanat Sakornsakolpat | Helen L Booth | William A Fahy | Simon P Hart | Mike R Hill | Vidyia Navaratnam | Eunice Oballa | Gauri Saini | Victor E Ortega | Philip L Molyneaux | A. Dressen | R. Putman | G. Saini | E. Oballa | R. Braybrooke | M. Neighbors | Luke M. Kraven | V. Navaratnam | Shwu-Fan Ma | Megan L. Paynton | A. Morris | Xuting R Sheng | L. M. Kraven | Yingze Zhang | N. Kaminski | M. Neighbors | X. R. Sheng | A. Morris
[1] P. Donnelly,et al. A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.
[2] Brent S. Pedersen,et al. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia , 2016, BMC Genetics.
[3] M. Karsdal,et al. The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis , 2019, Nature Communications.
[4] Nicola J. Rinaldi,et al. Genetic effects on gene expression across human tissues , 2017, Nature.
[5] L. Wain,et al. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis , 2019, bioRxiv.
[6] Christopher R. Cabanski,et al. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. , 2018, The Lancet. Respiratory medicine.
[7] J. Loyd,et al. Telomeres revisited: RTEL1 variants in pulmonary fibrosis , 2015, European Respiratory Journal.
[8] Ewan Birney,et al. GARFIELD - GWAS Analysis of Regulatory or Functional Information Enrichment with LD correction , 2016, bioRxiv.
[9] Blair H. Smith,et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell type and phenotype associations , 2019, Nature Genetics.
[10] Qunyuan Zhang,et al. Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations , 2014, BMJ Open Respiratory Research.
[11] R. Medema,et al. Kif15 Cooperates with Eg5 to Promote Bipolar Spindle Assembly , 2009, Current Biology.
[12] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[13] S. Mane,et al. Exome Sequencing Links Mutations in PARN and RTEL1 with Familial Pulmonary Fibrosis and Telomere Shortening , 2015, Nature Genetics.
[14] S. Kudoh,et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis , 2008, Journal of Medical Genetics.
[15] Jon Wakefield,et al. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.
[16] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[17] Zhenshun Cheng,et al. Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis , 2018, Human mutation.
[18] Mulin Jun Li,et al. Nature Genetics Advance Online Publication a N a Ly S I S the Support of Human Genetic Evidence for Approved Drug Indications , 2022 .
[19] W. Coward,et al. The pathogenesis of idiopathic pulmonary fibrosis , 2010, Therapeutic advances in respiratory disease.
[20] Fred A. Wright,et al. Conditional eQTL analysis reveals allelic heterogeneity of gene expression , 2017, Human molecular genetics.
[21] D. Goldstein,et al. An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis , 2017, American journal of respiratory and critical care medicine.
[22] Raúl San José Estépar,et al. MUC5B promoter polymorphism and interstitial lung abnormalities. , 2013, The New England journal of medicine.
[23] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[24] David C. Nickle,et al. Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma , 2012, PLoS genetics.
[25] F. Cunningham,et al. The Ensembl Variant Effect Predictor , 2016, Genome Biology.
[26] H. Abboud,et al. TGFβ-Induced Deptor Suppression Recruits mTORC1 and Not mTORC2 to Enhance Collagen I (α2) Gene Expression , 2014, PloS one.
[27] Don D. Sin,et al. Refining Susceptibility Loci of Chronic Obstructive Pulmonary Disease with Lung eqtls , 2013, PloS one.
[28] L. Wain,et al. Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.
[29] Joyce S Lee,et al. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. , 2014, The Lancet. Respiratory medicine.
[30] Ewan Birney,et al. FORGE: A tool to discover cell specific enrichments of GWAS associated SNPs in regulatory regions , 2014, bioRxiv.
[31] Josyf Mychaleckyj,et al. Robust relationship inference in genome-wide association studies , 2010, Bioinform..
[32] G. Verleden,et al. A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis , 2018, Respiratory Research.
[33] Xinli Hu,et al. SNPsea: an algorithm to identify cell types, tissues and pathways affected by risk loci , 2014, Bioinform..
[34] Bill B. Chen,et al. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury , 2015, Science Translational Medicine.
[35] P. Lansdorp,et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis , 2008, Proceedings of the National Academy of Sciences.
[36] Carlos Flores,et al. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study , 2017, The Lancet. Respiratory medicine.
[37] Jin Man Kim,et al. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. , 2008, Cancer genetics and cytogenetics.
[38] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[39] Shandra L. Protzko,et al. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. , 2015, American journal of respiratory and critical care medicine.
[40] M. J. Thompson,et al. Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes , 2015, PloS one.
[41] Biao Xu,et al. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis , 2015, Medicine.
[42] Brent S. Pedersen,et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.
[43] B. Stripp,et al. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. , 2016, JCI insight.
[44] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[45] Benjamin B. Sun,et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. , 2018, Nature Genetics.
[46] Ivana V. Yang,et al. Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.
[47] Harry J de Koning,et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis , 2017, Nature Genetics.
[48] Takeshi Johkoh,et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.
[49] Calum MacAulay,et al. Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small‐cell lung cancer cell lines , 2006, Genes, chromosomes & cancer.
[50] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[51] O. Troyanskaya,et al. Predicting effects of noncoding variants with deep learning–based sequence model , 2015, Nature Methods.
[52] L. Wain,et al. GSTCD and INTS12 Regulation and Expression in the Human Lung , 2013, PloS one.
[53] Naftali Kaminski,et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.
[54] P. Revy,et al. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis , 2015, European Respiratory Journal.
[55] H. Hatabu,et al. Interstitial Lung Abnormalities Are Associated with Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.
[56] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[57] V. Poletti,et al. The pathogenesis of COPD and IPF: Distinct horns of the same devil? , 2012, Respiratory Research.
[58] Jack Euesden,et al. PRSice: Polygenic Risk Score software , 2014, Bioinform..
[59] Raúl San José Estépar,et al. The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes , 2017, European Respiratory Journal.